Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Luzi

Showing results (41-50 of 56) with videos related to

Pageof 6
Sort By:
Minerva Medica|September 11, 2002
Efficacy of anthracyclines and paclitaxel as first line chemotherapy in patients with visceral metastases of breast cancerD Rossi, F Graziano, S Luzi Fedeli, et al.
Revue D'Epidemiologie Et De Sante Publique|October 1, 1996
Predicting the accrual rate in a vaccine clinical trial: an a posteriori evaluation of the feasibility studyA E Tozzi, M L Cofi Degli Atti, P Panei, et al.
La Radiologia Medica|April 1, 1997
[The anal canal: 2 cycles of radiochemotherapy and boost brachytherapy]V Valentini, G Mantello, S Luzi, et al.
Recenti Progressi in Medicina|January 1, 1986
[5-Fluorouracil (5-FU) cardiotoxicity. Evaluation by dynamic ECG]F Pellegrini, G Di Noto, G Ansuini, et al.
Vaccine|June 2, 1998
Predictors of adverse events after the administration of acellular and whole-cell diphtheria-tetanus-pertussis vaccinesA E Tozzi, M L Ciofi degli Atti, S G Wassilak, et al.
Anticancer Research|January 18, 2003
A new cisplatin/gemcitabine schedule in locally advanced (IIIB) and metastatic (IV) non-small cell lung cancer: relationship between dose-intensity and efficacy. A phase II studyD Rossi, F Graziano, V Catalano, et al.
Onkologie|September 16, 2003
Concomitant gemcitabine (Gemzar) and extended nodes irradiation in the treatment of pancreatic and biliary carcinoma: a phase I studyA G Morganti, L Trodella, V Valentini, et al.
Targeted Oncology|October 5, 2010
Activity and safety of erlotinib as second- and third-line treatment in elderly patients with advanced non-small cell lung cancer: a phase II trialDavid Rossi, Donatella Dennetta, Marcello Ugolini, et al.
World Journal of Oncology|November 18, 2017
"Short Course" of Nonpegylated Liposomal Doxorubicin Plus Paclitaxel and Trastuzumb as Primary Systemic Therapy for Operable and Locally-Advanced Breast Cancer: A Phase II Study (PacLiDox 07)D Rossi, B Pistilli, D Morale, et al.
International Journal of Radiation Oncology, Biology, Physics|March 8, 2000
Combined modality treatment in unresectable extrahepatic biliary carcinomaA G Morganti, L Trodella, V Valentini, et al.
Pageof 6

Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
Minerva Medica|September 11, 2002
Efficacy of anthracyclines and paclitaxel as first line chemotherapy in patients with visceral metastases of breast cancerD Rossi, F Graziano, S Luzi Fedeli, et al.
Revue D'Epidemiologie Et De Sante Publique|October 1, 1996
Predicting the accrual rate in a vaccine clinical trial: an a posteriori evaluation of the feasibility studyA E Tozzi, M L Cofi Degli Atti, P Panei, et al.
La Radiologia Medica|April 1, 1997
[The anal canal: 2 cycles of radiochemotherapy and boost brachytherapy]V Valentini, G Mantello, S Luzi, et al.
Recenti Progressi in Medicina|January 1, 1986
[5-Fluorouracil (5-FU) cardiotoxicity. Evaluation by dynamic ECG]F Pellegrini, G Di Noto, G Ansuini, et al.
Vaccine|June 2, 1998
Predictors of adverse events after the administration of acellular and whole-cell diphtheria-tetanus-pertussis vaccinesA E Tozzi, M L Ciofi degli Atti, S G Wassilak, et al.
Anticancer Research|January 18, 2003
A new cisplatin/gemcitabine schedule in locally advanced (IIIB) and metastatic (IV) non-small cell lung cancer: relationship between dose-intensity and efficacy. A phase II studyD Rossi, F Graziano, V Catalano, et al.
Onkologie|September 16, 2003
Concomitant gemcitabine (Gemzar) and extended nodes irradiation in the treatment of pancreatic and biliary carcinoma: a phase I studyA G Morganti, L Trodella, V Valentini, et al.
Targeted Oncology|October 5, 2010
Activity and safety of erlotinib as second- and third-line treatment in elderly patients with advanced non-small cell lung cancer: a phase II trialDavid Rossi, Donatella Dennetta, Marcello Ugolini, et al.
World Journal of Oncology|November 18, 2017
"Short Course" of Nonpegylated Liposomal Doxorubicin Plus Paclitaxel and Trastuzumb as Primary Systemic Therapy for Operable and Locally-Advanced Breast Cancer: A Phase II Study (PacLiDox 07)D Rossi, B Pistilli, D Morale, et al.
International Journal of Radiation Oncology, Biology, Physics|March 8, 2000
Combined modality treatment in unresectable extrahepatic biliary carcinomaA G Morganti, L Trodella, V Valentini, et al.
Pageof 6